Husch Blackwell LLP
Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
A method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic immunomodulatory anticancer agent. A further method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic targeted anticancer agent. The present invention is further directed to pharmaceutical compositions for treatment of cancer. The intralesional chemoablative pharmaceutical composition can comprise an IL chemoablative agent comprising primarily a halogenated xanthene.
Pfizer, Inc. Provectus Pharmatech, Inc.
A A A A A A A A A C A A A A A C C A A A A A A A C A A A A A
A61P A61P A61K A61K A61K A61K A61P A61K A61K C12N A61K A61K A61P A61P A61K C12N C07K A61K A61K A61K A61K A61K A61K A61K C12N A61K A61K A61K A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional
Craig J. Jamie H. Craig Eric A.
Eagle Singer Dees Wachter